Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This World Diabetes Day, we’re inviting you to celebrate by wearing your most joyful, whimsical and downright wonderful outfits.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Type 1 Diabetes Grand Challenge launches first research call
Following the exciting announcement in April about a new partnership between the Steve Morgan Foundation, Diabetes UK and JDRF to invest £50m into game-changing type 1 diabetes research, we have opened our first funding round, calling scientists to submit research proposals that could be transformational for people with type 1 diabetes.
First-class research cannot happen without first class researchers. Diabetes UK and JDRF are committed to nurturing the diabetes research leaders of the future, so for the first research call we have worked together to develop a new senior fellowship programme.
Fellowships are awards for individual researchers that support them to develop their careers, build their own research teams, and make diabetes research their life’s work.
The new Type 1 Diabetes Senior Research Fellowship will allow exceptional researchers, with a track-record of impactful research, to become world leaders in their field and lead the race for new treatments and a cure for type 1 diabetes.
The fellowship will award scientists up to £1.5 million to research:
These areas, along with novel insulins, were identified as carrying the most potential to improve the lives of people with type 1 diabetes and propel us towards a cure.
Rachel Connor, Director of Research Partnerships at JDRF, said:
“We believe in the power of research to one day lift the burden of living with type 1 diabetes, and alongside our partners in the Type 1 Diabetes Grand Challenge we are proud to launch this Senior Fellowship to enable researchers to pursue new ideas to transform lives for people with type 1 diabetes.
We can’t wait to see how this opportunity will deliver in supporting the cutting edge research that the Type 1 Diabetes Grand Challenge has set out to inspire.”
The research community will have until September 2022 to shape their ideas and apply for the fellowship. Diabetes UK and JDRF will then work with research experts and people living with or affected by type 1 diabetes to review the applications. They will select those submitted by researchers with exceptional track-records and that involve the highest quality science, with the greatest chance of benefiting people with type 1 diabetes. We expect to announce the final funding decisions in early 2023 and will keep you updated.
This fellowship will be administered by Diabetes UK on behalf of the Type 1 Diabetes Grand Challenge Partnership.
If you’re a diabetes researcher, find out more information about the call and application process.
A study we helped conduct, which has just been published, reveals the most important unanswered questions about type 1 diabetes, based on the priorities of adults in the United Kingdom and Ireland. This will help guide future research to focus on what matters most to people living with the condition.
When given to mice and pigs with type 1 diabetes, a new type of oral insulin developed with JDRF funding detects rising blood glucose and quickly lowers it to a safe level without causing hypos.
New research finds that ustekinumab, a drug commonly used to treat psoriasis, may help children and adolescents with type 1 diabetes keep making insulin for longer.
New international guidance detailing how to monitor and support people with early-stage type 1 diabetes (T1D) has the potential to reduce the trauma associated with being diagnosed with T1D, enable people to access the latest treatments to delay the need for insulin therapy, and reduce long-term health complications.
Our research is improving the lives of people with type 1 and making strides towards a cure. We’ll keep pushing until we make type 1 diabetes a thing of the past.
